Mustang Bio Stock Probability of Future Stock Price Finishing Under 0.21

MBIO Stock  USD 0.20  0.01  4.76%   
Mustang Bio's future price is the expected price of Mustang Bio instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Mustang Bio performance during a given time horizon utilizing its historical volatility. Check out Mustang Bio Backtesting, Mustang Bio Valuation, Mustang Bio Correlation, Mustang Bio Hype Analysis, Mustang Bio Volatility, Mustang Bio History as well as Mustang Bio Performance.
To learn how to invest in Mustang Stock, please use our How to Invest in Mustang Bio guide.
  
At this time, Mustang Bio's Price Book Value Ratio is very stable compared to the past year. As of the 26th of November 2024, Price Earnings To Growth Ratio is likely to grow to 0, while Price Earnings Ratio is likely to drop (0.24). Please specify Mustang Bio's target price for which you would like Mustang Bio odds to be computed.

Mustang Bio Target Price Odds to finish below 0.21

The tendency of Mustang Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to stay under $ 0.21  after 90 days
 0.20 90 days 0.21 
about 13.4
Based on a normal probability distribution, the odds of Mustang Bio to stay under $ 0.21  after 90 days from now is about 13.4 (This Mustang Bio probability density function shows the probability of Mustang Stock to fall within a particular range of prices over 90 days) . Probability of Mustang Bio price to stay between its current price of $ 0.20  and $ 0.21  at the end of the 90-day period is about 5.1 .
Given the investment horizon of 90 days Mustang Bio has a beta of -0.9. This indicates Additionally Mustang Bio has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Mustang Bio Price Density   
       Price  

Predictive Modules for Mustang Bio

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Mustang Bio. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.010.196.20
Details
Intrinsic
Valuation
LowRealHigh
0.224.4610.47
Details
1 Analysts
Consensus
LowTargetHigh
15.7017.2519.15
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.15-0.15-0.15
Details

Mustang Bio Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Mustang Bio is not an exception. The market had few large corrections towards the Mustang Bio's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Mustang Bio, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Mustang Bio within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.66
β
Beta against Dow Jones-0.9
σ
Overall volatility
0.04
Ir
Information ratio -0.14

Mustang Bio Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Mustang Bio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Mustang Bio can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Mustang Bio generated a negative expected return over the last 90 days
Mustang Bio has high historical volatility and very poor performance
Mustang Bio has some characteristics of a very speculative penny stock
Mustang Bio has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (51.6 M) with profit before overhead, payroll, taxes, and interest of 0.
Mustang Bio currently holds about 107.37 M in cash with (49.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.01, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Mustang Bio has a frail financial position based on the latest SEC disclosures
Latest headline from seekingalpha.com: Mustang Bio files to sell 34.77M shares of common stock for holders

Mustang Bio Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Mustang Stock often depends not only on the future outlook of the current and potential Mustang Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Mustang Bio's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding8.6 M
Cash And Short Term Investments6.2 M

Mustang Bio Technical Analysis

Mustang Bio's future price can be derived by breaking down and analyzing its technical indicators over time. Mustang Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Mustang Bio. In general, you should focus on analyzing Mustang Stock price patterns and their correlations with different microeconomic environments and drivers.

Mustang Bio Predictive Forecast Models

Mustang Bio's time-series forecasting models is one of many Mustang Bio's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Mustang Bio's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Mustang Bio

Checking the ongoing alerts about Mustang Bio for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Mustang Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Mustang Bio generated a negative expected return over the last 90 days
Mustang Bio has high historical volatility and very poor performance
Mustang Bio has some characteristics of a very speculative penny stock
Mustang Bio has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (51.6 M) with profit before overhead, payroll, taxes, and interest of 0.
Mustang Bio currently holds about 107.37 M in cash with (49.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.01, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Mustang Bio has a frail financial position based on the latest SEC disclosures
Latest headline from seekingalpha.com: Mustang Bio files to sell 34.77M shares of common stock for holders
When determining whether Mustang Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Mustang Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mustang Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mustang Bio Stock:
Check out Mustang Bio Backtesting, Mustang Bio Valuation, Mustang Bio Correlation, Mustang Bio Hype Analysis, Mustang Bio Volatility, Mustang Bio History as well as Mustang Bio Performance.
To learn how to invest in Mustang Stock, please use our How to Invest in Mustang Bio guide.
You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mustang Bio. If investors know Mustang will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mustang Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.27)
Revenue Per Share
(0)
Return On Assets
(0.97)
Return On Equity
(11.91)
The market value of Mustang Bio is measured differently than its book value, which is the value of Mustang that is recorded on the company's balance sheet. Investors also form their own opinion of Mustang Bio's value that differs from its market value or its book value, called intrinsic value, which is Mustang Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mustang Bio's market value can be influenced by many factors that don't directly affect Mustang Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mustang Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mustang Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mustang Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.